[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Medical News & Perspectives
September 19, 2001

Clinical Trials to Receive a Boost, But How Big?

Author Affiliations

Not Available

Not Available

JAMA. 2001;286(11):1303-1304. doi:10.1001/jama.286.11.1303-JMN0919-2-1

Washington—If President George W. Bush signs into law some compromise version of the Patients' Bill of Rights, one provision in both the House and Senate bills as JAMA went to press would provide clinical research with a much-needed boost: mandatory insurance coverage of the so-called routine costs of care for patients in clinical trials.

For a decade, cancer care advocates and other patient advocacy groups have been pushing for the rule. They argue that denying usual care to patients because they choose to aid research is not only unfair but inhumane. And while many insurance companies already pay for such costs, patients usually believe that if they join a trial, they will be hit with extra fees.

First Page Preview View Large
First page PDF preview
First page PDF preview